“[18F]FDG PET Immunotherapy Radiomics Signature (iRADIOMICS) Predicts Response of Non-Small-Cell Lung Cancer Patients Treated With Pembrolizumab”. Radiology and Oncology 54, no. 3 (September 2, 2020): 285–294. Accessed October 10, 2026. https://radioloncol.com/index.php/ro/article/view/3452.